Predictors of long-term treatment outcome in combat and peacekeeping veterans with military-related PTSD

Journal of Clinical Psychiatry

Volumn 75, Issue 11, 2014, Pages e1299-e1305

  Richardson, J Don ^a,b   Contractor, Ateka A ^d   Armour, Cherie ^f   St Cyr, Kate ^a   Elhai, Jon D ^d,e   Sareen, Jitender ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF TOLEDO   (United States)

^e MEDICAL COLLEGE OF OHIO   (United States)

^f UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT;

ADULT; ALCOHOL ABUSE; ARTICLE; BECK DEPRESSION INVENTORY; COMORBIDITY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HELP SEEKING BEHAVIOR; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE ASSESSMENT; MILITARY SERVICE; OUTCOME ASSESSMENT; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; PTSD CHECKLIST MILITARY VERSION; RETROSPECTIVE STUDY; SHORT FORM 36; TREATMENT RESPONSE; VETERAN; COMBAT DISORDERS; MIDDLE AGED; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TIME; TREATMENT OUTCOME;

ADULT; COMBAT DISORDERS; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TIME FACTORS; TREATMENT OUTCOME; VETERANS;

EID: 84926662067     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.13m08796     Document Type: Article

References (100)

1. Litz BT. The psychological demands of peacekeeping. PTSD Clin Q. 1996;6(1):1-8.
2. Litz BT, King LA, King DW, et al. Warriors as peacekeepers: features of the Somalia experience and PTSD. J Consult Clin Psychol. 1997;65(6):1001-1010. doi:10.1037/02-06X.65.6.101 PubMed
3. Litz BT, Orsillo SM, Friedman M, et al. Posttraumatic stress disorder associated with peacekeeping duty in Somalia for US military personnel. Am J Psychiatry. 1997;154(2):178-184. PubMed
4. Hoge CW, Auchterlonie JL, Milliken CS. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA. 2006;295(9):1023-1032. doi:10.101/jama.295.9.1023 PubMed
5. Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. 2004;351(1):13-22. doi:10.1056/NEJMoa040603 PubMed
6. Lapierre CB, Schwegler AF, Labauve BJ. Posttraumatic stress and depression symptoms in soldiers returning from combat operations in Iraq and Afghanistan. J Trauma Stress. 2007;20(6):933-943. doi:10.102/jts.20278 PubMed
7. Seal K, Bertenthal D, Miner C, et al. Bringing the war back home: mental health disorders among 103,788 US Veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities. Arch Intern Med. 2007;167(5):476-482. doi:10.101/archinte.167.5.476 PubMed
8. Sundin J, Fear NT, Iversen A, et al. PTSD after deployment to Iraq: conflicting rates, conflicting claims. Psychol Med. 2010;40(3):367-382. doi:10.1017/S032917090791 PubMed
9. Tanielian T, Jaycox L. Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery. Santa Monica, CA: The RAND Center for Military Health Policy Research; 2008.
10. Statistics Canada. Canadian Community Health Survey Cycle 1.2-Mental Health and Well-being (Canadian Forces Supplement). Ottawa, Canada: Statistics Canada; 2002.
11. Richardson JD, Elhai JD, Pedlar DJ. Association of PTSD and depression with medical and specialist care utilization in modern peacekeeping veterans in Canada with health-related disabilities. J Clin Psychiatry. 2006;67(8):1240-1245. doi:10.408/JCP.v67n0810 PubMed
12. Creamer M, Forbes D, Biddle D, et al. Inpatient versus day hospital treatment for chronic, combat-related posttraumatic stress disorder: A naturalistic comparison. J Nerv Ment Dis. 2002;190(3):183-189. doi:10.1097/05053-202030-07 PubMed
13. Richardson JD, Long ME, Pedlar D, et al. Posttraumatic stress disorder and health-related quality of life among a sample of treatment-and pensionseeking deployed Canadian Forces peacekeeping veterans. Can J Psychiatry. 2008;53(9):594-600. PubMed
14. Schoenfeld FB, Marmar CR, Neylan TC. Current concepts in pharmacotherapy for posttraumatic stress disorder. Psychiatr Serv. 2004;55(5):519-531. doi:10.176/api.ps.5.5.519 PubMed
15. Bradley R, Greene J, Russ E, et al. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry. 2005;162(2):214-227. doi:10.176/api.ajp.162.2.214 PubMed
16. Institute of Medicine (IOM). Treatment of PTSD: an Assessment of the Evidence. Washington, DC: National Academies Press; 2008.
17. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048-1060. doi:10.101/archpsyc.195.039502406012 PubMed
18. Forbes D, Creamer M, Hawthorne G, et al. Comorbidity as a predictor of symptom change after treatment in combat-related posttraumatic stress disorder. J Nerv Ment Dis. 2003;191(2):93-99. doi:10.1097/01.NMD.051903.60517.98 PubMed
19. Keane TM, Wolfe J. Comorbidity in post-traumatic stress disorder: an analysis of community and clinical studies. J Appl Soc Psychol. 1990;20(21):1776-1788. doi:10.1/j.159-1816.190.tb0151.x
20. Southwick SM, Yehuda R, Giller EL Jr. Characterization of depression in warrelated posttraumatic stress disorder. Am J Psychiatry. 1991;148(2):179-183. PubMed
21. Foa EB. Psychosocial therapy for posttraumatic stress disorder. J Clin Psychiatry. 2006;67(suppl 2):40-45. PubMed
22. Benedek DM, Friedman MJ, Zatzick D, et al. Guideline Watch: Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder. Washington, DC: American Psychiatric Publishing; 2009.
23. American Psychiatric Association. Practice guidelines for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry. 2004;161(November):1-57.
24. US Department of Veterans Affairs, Department of Defense. Clinical Practice Guideline for Management of Post-Traumatic Stress. Washington, DC: Veterans Health Administration, Department of Defense; 2010.
25. Australian Centre for Posttraumatic Mental Health. Australian Guidelines for the Treatment of Acute Stress Disorder and Posttraumatic Stress Disorder. http://www.acpmh.unimelb.edu.au/resources/resources-guidelines.html. Updated June 17, 2014. Accessed September 8, 2014.
26. Canadian Psychiatric Association. Clinical practice guidelines for the treatment of anxiety disorders. Can J Psychiatry. 2006;51(suppl 2): 57-63. https://ww1.cpa-apc.org/Publications/CJP/supplements/july2006/anxiety-guidelines-2006.pdf. Accessed August 23, 2014.
27. Foa EB. Prolonged exposure therapy: past, present, and future. Depress Anxiety. 2011;28(12):1043-1047. doi:10.102/da.20907 PubMed
28. Rauch SA, Defever E, Favorite T, et al. Prolonged exposure for PTSD in a Veterans Health Administration PTSD clinic. J Trauma Stress. 2009;22(1):60-64. doi:10.102/jts.20380 PubMed
29. Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006;74(5):898-907. doi:10.1037/02-06X.74.5.898 PubMed
30. Resick PA, Monson CM, Chard KM. Cognitive processing therapy: veteran/ military version; 2007 http://www.alrest.org/pdf/CPT-Manual-Modified-for-PRRP%282%29.pdf. Accessed August 23, 2014.
31. Zimmermann P, Biesold KH, Barre K, et al. Long-term course of posttraumatic stress disorder (PTSD) in German soldiers: effects of inpatient eye movement desensitization and reprocessing therapy and specific trauma characteristics in patients with non-combat-related PTSD. Mil Med. 2007;172(5):456-460. PubMed
32. van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007;68(1):37-46. doi:10.408/JCP.v68n0105 PubMed
33. Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006;19(5):625-638. doi:10.102/jts.20170 PubMed
34. Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: A controlled study. Arch Gen Psychiatry. 1998;55(4):317-325. doi:10.101/archpsyc.5.4.317 PubMed
35. Watts BV, Schnurr PP, Mayo L, et al. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2013;74(6):e541-e550. doi:10.408/JCP.12r0825 PubMed
36. Stewart CL, Wrobel TA. Evaluation of the efficacy of pharmacotherapy and psychotherapy in treatment of combat-related post-traumatic stress disorder: A meta-analytic review of outcome studies. Mil Med. 2009;174(5):460-469. doi:10.7205/MILMED-D-04-1507 PubMed
37. Shalev AY, Bonne O, Eth S. Treatment of posttraumatic stress disorder: A review. Psychosom Med. 1996;58(2):165-182. doi:10.1097/06842-196030-012 PubMed
38. Friedman MJ. Drug treatment for PTSD: answers and questions. Ann N Y Acad Sci. 1997;821:359-371. doi:10.1/j.1749-632.197.tb48292.x PubMed
39. Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2006;25(1):CD002795. PubMed
40. Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: A double-blind, placebo-controlled study. Am J Psychiatry. 2002;159(10):1777-1779. doi:10.176/api.ajp.159.10.17 PubMed
41. Hamner MB, Faldowski RA, Ulmer HG, et al. Adjunctive risperidone treatment in post-traumatic stress disorder: A preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol. 2003;18(1):1-8. doi:10.1097/04850-203010-01 PubMed
42. Monnelly EP, Ciraulo DA, Knapp C, et al. Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. J Clin Psychopharmacol. 2003;23(2):193-196. doi:10.1097/04714-203040-012 PubMed
43. Krystal JH, Rosenheck RA, Cramer JA, et al; Veterans Affairs Cooperative Study No. 504 Group. Adjunctive risperidone treatment for antidepressantresistant symptoms of chronic military service-related PTSD: A randomized trial. JAMA. 2011;306(5):493-502. doi:10.101/jama.201.1080 PubMed
44. Kennedy SH, Lam RW, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: introduction. J Affect Disord. 2009;117(suppl 1):S1-S2. doi:10.1016/j.jad.209.06.043 PubMed
45. Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry. 1999;45(9):1226-1229. doi:10.1016/S06-323(9)01-6 PubMed
46. Lipper S, Davidson JR, Grady TA, et al. Preliminary study of carbamazepine in post-traumatic stress disorder. Psychosomatics. 1986;27(12):849-854. doi:10.1016/S03-3182(86)72590-5 PubMed
47. Keck PE Jr, McElroy SL, Friedman LM. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol. 1992;12(suppl):36S-41S. doi:10.1097/04714-1920201-06 PubMed
48. Fesler FA. Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry. 1991;52(9):361-364. PubMed
49. Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: A preliminary report. J Clin Psychiatry. 2002;63(1):15-20. doi:10.408/JCP.v63n0104 PubMed
50. Hamner MB, Brodrick PS, Labbate LA. Gabapentin in PTSD: A retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry. 2001;13(3):141-146. doi:10.3109/10401230109148960 PubMed
51. Creamer M, Morris P, Biddle D, et al. Treatment outcome in Australian veterans with combat-related posttraumatic stress disorder: A cause for cautious optimism? J Trauma Stress. 1999;12(4):545-558. doi:10.1023/A:102470293164 PubMed
52. Johnson DR, Rosenheck R, Fontana A, et al. Outcome of intensive inpatient treatment for combat-related posttraumatic stress disorder. Am J Psychiatry. 1996;153(6):771-777. PubMed
53. Zatzick D, Roy-Byrne P, Russo J, et al. A randomized effectiveness trial of stepped collaborative care for acutely injured trauma survivors. Arch Gen Psychiatry. 2004;61(5):498-506. doi:10.101/archpsyc.61.5.498 PubMed
54. Chan D, Cheadle AD, Reiber G, et al. Health care utilization and its costs for depressed veterans with and without comorbid PTSD symptoms. Psychiatr Serv. 2009;60(12):1612-1617. doi:10.176/api.ps.60.12.1612 PubMed
55. Zatzick D, Rivara F, Jurkovich G, et al. Enhancing the population impact of collaborative care interventions: mixed method development and implementation of stepped care targeting posttraumatic stress disorder and related comorbidities after acute trauma. Gen Hosp Psychiatry. 2011;33(2):123-134. doi:10.1016/j.genhospsych.201.01.01 PubMed
56. Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: A randomized controlled trial. J Anxiety Disord. 2011;25(2):224-231. doi:10.1016/j.janxdis.2010.09.06 PubMed
57. Richardson JD, Long ME, Pedlar D, et al. Posttraumatic stress disorder and health-related quality of life in pension-seeking Canadian World War II and Korean War veterans. J Clin Psychiatry. 2010;71(8):1099-1101. doi:10.408/JCP.09l05920blu PubMed
58. Hourani LL, Yuan H. The mental health status of women in the Navy and Marine Corps: preliminary findings from the Perceptions of Wellness and Readiness Assessment. Mil Med. 1999;164(3):174-181. PubMed
59. Foa E, Keane T, Friedman L, et al. Introduction. In: Foa E, Keane T, Friedman LM, et al, eds. Effective Treatments for PTSD. New York, NY: The Guilford press; 2009:1-20.
60. King DW, King LA, Gudanowski DM, et al. Alternative representations of war zone stressors: relationships to posttraumatic stress disorder in male and female Vietnam veterans. J Abnorm Psychol. 1995;104(1):184-195. doi:10.1037/021-843X.104.1.184 PubMed
61. Creamer M, Forbes D. Treatment of posttraumatic stress disorder in military and veteran populations psychotherapy: theory, research, practice. Training. 2004;41(4):388-398.
62. Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007;68(5):711-720. doi:10.408/JCP.v68n0508 PubMed
63. Frueh BC, Elhai JD, Gold PB, et al. Disability compensation seeking among veterans evaluated for posttraumatic stress disorder. Psychiatr Serv. 2003;54(1):84-91. doi:10.176/api.ps.54.1.84 PubMed
64. Frueh BC, Hamner MB, Cahill SP, et al. Apparent symptom overreporting in combat veterans evaluated for PTSD. Clin Psychol Rev. 2000;20(7):853-885. doi:10.1016/S0272-7358(9)015-X PubMed
65. Raudenbush SW, Bryk AS, eds. Hierarchical Linear Models: Applications and Data Analysis Methods. 2nd ed. Thousand Oaks, CA: Sage Publications; 2002.
66. Snijders TAB, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. Thousand Oaks, CA: Sage; 2002.
67. National Centre for Operational Stress Injuries; St Annes de Bellview. Guidelines for Operational Stress Injury Clinics. Quebec, Canada: Veterans Affairs Canada; 2011.
68. Weathers FW, Litz BT, Herman DS, et al. The PTSD Checklist: Reliability, Validity, & Diagnostic Utility. Annual Meeting of the International Society for Traumatic Stress Studies. San Antonio, Texas: International Society for Traumatic Stress Studies; 1993.
69. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, Texas: Psychological Corporation; 1996.
70. Ware J, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: Quality Metric Incorporated; 2000.
71. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233. doi:10.1097/05650-196030-03 PubMed
72. Foa E, Keane T, Friedman L. Introduction. In: Foa EKT, Friedman LM, eds. Effective Treatments for PTSD. New York, NY: Guilford Press; 2000:1-17.
73. Turnbull G, McFarland A. Acute treatments. In: Van Der Kolk BA, McFarland A, Weisaeth L, ed. Traumatic Stress. New York, NY: Guilford Press; 1996:480-490.
74. Van Der Kolk B, McFarland A, Van Der Hart O. A general approach to treatment of posttraumatic stress disorder. In: Van Der Kolk B, McFarland A, Weisaeth L, eds. Traumatic Stress. New York, NY: Guilford Press; 1996:417-440.
75. Richardson JD, McIntosh DN, Stein M, et al. Careful assessment of comorbid mental and physical illness guides psychopharmacological treatment of posttraumatic stress disorder. Mood and Anxiety Disorders Rounds. 2010;1(6):1-6.
76. Blake DD, Weathers FW, Nagy LN, et al. A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1. Behav Therapist. 1990;18:187-188.
77. Weathers FW, Keane TM, Davidson JRT. Clinician-administered PTSD scale: A review of the first ten years of research. Depress Anxiety. 2001;13(3):132-156. doi:10.102/da.1029 PubMed
78. Weathers F, Ruscio A, Keane T. Psychometric properties of nine scoring rules for the Clinician-Administered Posttraumatic Stress Disorder Scale. Psychol Assess. 1999;11(2):124-133. doi:10.1037/1040-3590.1.2.124
79. Gray MJ, Lombardo TW. Life event attributions as a potential source of vulnerability following exposure to a traumatic event. J Loss Trauma. 2004;9(1):59-72. doi:10.1080/1532502049025313
80. Beck AT. The Diagnosis and Management of Depression. Philadelphia, PA: University of Pennsylvania Press; 1967.
81. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77-100. doi:10.1016/0272-7358(8)9050-5
82. Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995;56(4):423-432. PubMed
83. Allen JP, Litten RZ, Fertig JB, et al. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Clin Exp Res. 1997;21(4):613-619. doi:10.1/j.1530-027.197.tb0381.x PubMed
84. American Psychiatric Association. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association Press; 2000.
85. Ware JE Jr, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33(suppl):AS264-AS279. PubMed
86. Ware JE, Kosinski M, Keller SD. How to score the SF-12 Physical and Mental Health Summary Scales. Boston, MA: New England Medical Center, Health Institute; 1995.
87. McHorney CA, Ware JE Jr, Lu JF, et al. The MOS 36-item Short-Form Health Survey (SF-36): III. tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32(1):40-66. doi:10.1097/05650-194010-04 PubMed
88. Barrett DH, Doebbeling CC, Schwartz DA, et al. Posttraumatic stress disorder and self-reported physical health status among US Military personnel serving during the Gulf War period: A population-based study. Psychosomatics. 2002;43(3):195-205. doi:10.176/api.psy.43.3.195 PubMed
89. Malik ML, Connor KM, Sutherland SM, et al. Quality of life and posttraumatic stress disorder: A pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine. J Trauma Stress. 1999;12(2):387-393. doi:10.1023/A:1024745030140 PubMed
90. Simon NM, Otto MW, Korbly NB, et al. Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatr Serv. 2002;53(6):714-718. doi:10.176/api.ps.53.6.714 PubMed
91. Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project: International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171-1178. doi:10.1016/S0895-4356(98)0109-7 PubMed
92. Bajor LA, Lai Z, Goodrich DE, et al. Posttraumatic stress disorder, depression, and health-related quality of life in patients with bipolar disorder: review and new data from a multi-site community clinic sample. J Affect Disord. 2013;145(2):232-239. doi:10.1016/j.jad.2012.08.05 PubMed
93. Bollen K, Curran P. Latent Curve Models. A Structural Equation Perspective. Hoboken, NJ: John Wiley and Sons; 2006.
94. Muthén BO, Muthén LK. Mplus. 5th ed. Los Angeles, CA: Muthén and Muthén; 2007.
95. Yuan KH, Bentler PM. Three likelihood-based methods for mean and covariance structure analysis with nonnormal missing data. In: Sobel ME, Becker MP, eds. Sociological Methodology. Washington, DC: Wiley-Blackwell; 2000:165-200. doi:10.1/081-1750.078
96. Davidson JRT. Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. J Clin Psychiatry. 2000;61(suppl 5):52-56, discussion 57-59. PubMed
97. Ehlers A, Clark DM, Hackmann A, et al. Cognitive therapy for posttraumatic stress disorder: development and evaluation. Behav Res Ther. 2005;43(4):413-431. doi:10.1016/j.brat.204.03.06 PubMed
98. Davidson JR, Kudler HS, Saunders WB, et al. Predicting response to amitriptyline in posttraumatic stress disorder. Am J Psychiatry. 1993;150(7):1024-1029. PubMed
99. Davidson JRT. Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. J Clin Psychiatry. 2000;61(suppl 5):52-56, discussion 57-59. Pu
100. Shalev AY. Measuring outcome in posttraumatic stress disorder. J Clin Psychiatry. 2000;61(suppl 5):33-39, discussion 40-42. PubMed